Abstract:We have previously reported that tumor necrosis factor receptor-associated factor 1 (TRAF1), an intracellular protein, which binds to a range of molecules, including tumor necrosis factor (TNF) receptor family members, regulates TNF-induced NF-kappaB and AP-1 signaling as well as TCR-triggered proliferative responses in T cells. In order to define the role of TRAF1 in Th cell differentiation, we analyzed the responses of TRAF1-/- T cells following TCR activation. Stimulation of TRAF1-/- T cells by antigen resulted in significantly increased expression of the Th2 cytokines (IL-4, IL-5 and IL-13) compared with wild-type (WT) controls. The Th2 bias of TRAF1-/- T cells is T lymphocyte intrinsic, since naive CD4+CD62L+ TRAF1-/- T cells activated with CD3/CD28 produced elevated levels of Th2 cytokines. Consistent with these observations in cultured T cells, TRAF1-/- T cells induced enhanced Th2 responses in vivo. Transfer of ovalbumin (OVA)-immune TRAF1-/- T cells into naive WT recipients conferred significantly more intense pulmonary inflammation and higher airway hyperresponsiveness following inhaled OVA challenge than did transfer of OVA-immune WT T cells. Biochemical analysis of TRAF1-/- T cells revealed that they have elevated nuclear expression of NFAT-interacting protein (NIP45), a Th2 cell-associated transcription factor known to potentiate NFATp-driven IL-4 expression. In further experiments, we demonstrated that TRAF1 associates with a fraction of NIP45 in the cytoplasm and prevents its translocation to the nucleus. Taken together these results suggest that TRAF1 may limit the induction of Th2 responses by decreasing NIP45 concentration to the nucleus and thereby down-regulating the expression of NIP45-dependent IL-4 gene transcription.

Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity

The Transcriptional Co-factor IRF2BP2: A New Player in Tumor Development and Microenvironment

Transcription factors of the NFAT family: regulation and function.

Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45)

Hepatic IRF2BP2 Mitigates Nonalcoholic Fatty Liver Disease by Directly Repressing the Transcription of ATF3

NFATC3 promotes IRF7 transcriptional activity in plasmacy--toid dendritic cells.

Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells

Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cells

The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action

Prox1 Represses Il-2 Gene Expression By Interacting With Nfat2

Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes

BATF-JUN is critical for IRF4-mediated transcription in T cells

Transcriptional Activity of Interferon Regulatory Factor (IRF)-3 Depends on Multiple Protein-Protein Interactions.

FOXP3 controls regulatory T cell function through cooperation with NFAT.

The Nuclear Factor Yy1 Suppresses the Human Gamma Interferon Promoter Through Two Mechanisms: Inhibition of Ap1 Binding and Activation of A Silencer Element

FOXP3 Interactions with Histone Acetyltransferase and Class II Histone Deacetylases Are Required for Repression

TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45

Repression of Interferon-Γ Expression in T Cells by Prospero-related Homeobox Protein

Nuclear respiratory factor 2 induces the expression of many but not all human proteins acting in mitochondrial DNA transcription and replication

NIP45 controls the magnitude of the type 2 T helper cell response

Control of Pathological Cardiac Hypertrophy by Transcriptional Corepressor IRF2BP2 (interferon Regulatory Factor-2 Binding Protein 2).